Company: TVRD
Filing Date: 2025-10-20
Form Type: S-8
Source: 0001104659-25-100898
Chunk: 8

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-20
Form: S-8
Chunk 8
---
 name, place and stead, in any and all capacities,
to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with all exhibits
thereto, and other documents in connection therewith, with the Securities and Exchange Commission, and generally to do all such things
in their names and behalf in their capacities as officers and directors to enable Tvardi Therapeutics, Inc. to comply with the provisions
of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, granting unto said attorneys-in-fact
and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done
in connection therewith, as fully to all intents and purposes as he might or could do in person, ratifying and confirming all that said
attorneys-in-fact and agents, or any of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue
hereof.

Pursuant to the requirements of the Securities
Act of 1933, as amended, this registration statement on Form S-8 has been signed by the following persons in the capacities and on
the dates indicated.

| Signature                
 /s/ Imran Alibhai, Ph.D. |     | Title                                            
 Chief Executive Officer and Director             |     | Date             
 October 20, 2025 |
|:-------------------------|:----|:-------------------------------------------------|:----|:-----------------|
| Imran Alibhai, Ph.D.     |     | -Principal Executive Officer                     |     |                  |
| /s/ Dan Conn, J.D., MBA  |     | Chief Financial Officer                          |     | October 20, 2025 |
| Dan Conn, J.D., MBA      |     | -Principal Financial Officer                     |     |                  |
| /s/ Stephen O’Brien      |     | Vice President, Finance and Corporate Controller |     | October 20, 2025 |
| Stephen O’Brien          |     | -Principal Accounting Officer                    |     |                  |
| /s/ Sujal Shah           |     | Chairman                                         |     | October 20, 2025 |
| Sujal Shah               |     |                                                  |     |                  |
| /s/ Wallace Hall         |     | Director                                         |     | October 20, 2025 |
| Wallace Hall             |     |